Latest Insider Transactions at Enzon Pharmaceuticals, Inc. (ENZN)
This section provides a real-time view of insider transactions for Enzon Pharmaceuticals, Inc. (ENZN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of ENZON PHARMACEUTICALS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of ENZON PHARMACEUTICALS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 16
2023
|
Randolph C Read Director |
BUY
Open market or private purchase
|
Direct |
84,550
+29.71%
|
$0
$0.14 P/Share
|
|
Jun 14
2023
|
Randolph C Read Director |
BUY
Open market or private purchase
|
Direct |
15,000
+11.5%
|
$0
$0.13 P/Share
|
|
Aug 13
2021
|
Jonathan Couchman > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
107,500
-7.62%
|
$0
$0.39 P/Share
|
|
Nov 18
2020
|
Randolph C Read Director |
BUY
Open market or private purchase
|
Direct |
50,000
+33.23%
|
$0
$0.16 P/Share
|
|
Nov 16
2020
|
Randolph C Read Director |
BUY
Open market or private purchase
|
Direct |
50,450
+50.0%
|
$0
$0.15 P/Share
|
|
Nov 13
2020
|
Jordan Bleznick Director |
BUY
Open market or private purchase
|
Direct |
100,000
+50.0%
|
$0
$0.15 P/Share
|
|
Oct 09
2020
|
Icahn Carl C > 10% Shareholder |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
39,277
+50.0%
|
-
|
|
Oct 09
2020
|
Icahn Carl C > 10% Shareholder |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
29,457,750
+44.96%
|
-
|